ALKS 8-K 2026-08-12

Alkermes plc. (ALKS) 8-K dated 2026-08-12 — accession 0001193125-26-345901. This URL is the filing, not the ALKS hub.

Alkermes plc. (ALKS) is a drug manufacturers - specialty & generic company listed on US.

Alkermes plc. filed a 8-K on 2026-08-12. Accession 0001193125-26-345901.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALKS revenue for 2026-06-30 was $888.9M. Net income was -$66.0M. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.

Not investment advice. The ALKS SEC hub lists recent forms. The stock page is the research view.